Privia Health Group (NASDAQ:PRVA) CFO Sells $432,995.28 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 17,196 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $25.18, for a total value of $432,995.28. Following the sale, the chief financial officer directly owned 211,462 shares in the company, valued at $5,324,613.16. This trade represents a 7.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The stock was sold at an average price of $22.60, for a total value of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total value of $179,690.37.
• On Thursday, April 2nd, David Mountcastle sold 5,566 shares of Privia Health Group stock. The shares were sold at an average price of $20.85, for a total value of $116,051.10.

Privia Health Group Trading Up 0.7%

Shares of PRVA stock traded up $0.18 during mid-day trading on Tuesday, reaching $25.73. The stock had a trading volume of 863,376 shares, compared to its average volume of 928,529. The company has a market cap of $3.24 billion, a P/E ratio of 160.82, a price-to-earnings-growth ratio of 2.02 and a beta of 0.90. Privia Health Group, Inc. has a 12-month low of $18.77 and a 12-month high of $26.51. The business has a 50-day simple moving average of $23.22 and a 200 day simple moving average of $22.95.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.11. Privia Health Group had a net margin of 0.97% and a return on equity of 2.81%. The firm had revenue of $603.85 million for the quarter, compared to analysts’ expectations of $560.99 million. During the same period in the prior year, the company earned $0.22 EPS. The firm’s revenue was up 25.8% on a year-over-year basis. Research analysts anticipate that Privia Health Group, Inc. will post 0.27 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently commented on PRVA. Evercore set a $26.00 price target on shares of Privia Health Group in a research report on Wednesday, April 8th. Canaccord Genuity Group reduced their target price on Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Truist Financial increased their target price on Privia Health Group from $31.00 to $33.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Weiss Ratings downgraded Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. Finally, Citigroup cut their price target on Privia Health Group from $34.00 to $32.00 and set a “buy” rating for the company in a report on Tuesday, March 3rd. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $31.15.

Institutional Investors Weigh In On Privia Health Group

Hedge funds and other institutional investors have recently modified their holdings of the company. Durable Capital Partners LP raised its position in shares of Privia Health Group by 1.8% in the third quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company’s stock valued at $291,123,000 after buying an additional 203,842 shares during the last quarter. State Street Corp grew its stake in Privia Health Group by 1.5% in the 2nd quarter. State Street Corp now owns 4,171,069 shares of the company’s stock worth $95,935,000 after acquiring an additional 61,853 shares during the period. Van Berkom & Associates Inc. grew its stake in Privia Health Group by 5.4% in the 1st quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock worth $83,371,000 after acquiring an additional 208,787 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Privia Health Group by 1.1% during the fourth quarter. Geode Capital Management LLC now owns 2,814,290 shares of the company’s stock worth $66,738,000 after purchasing an additional 31,204 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in shares of Privia Health Group by 1.6% during the fourth quarter. Principal Financial Group Inc. now owns 2,787,802 shares of the company’s stock worth $66,099,000 after purchasing an additional 43,589 shares during the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.